Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised EQT IX in connection with sale of shares in Beijer Ref AB (publ)
Mandate

Vinge has advised EQT IX in connection with sale of shares in Beijer Ref AB (publ)

June 22, 2023 M&A

Vinge has advised EQT IX (”EQT”) in connection with the sale of shares in Beijer Ref AB (publ) through an accelerated bookbuilding process carried out on 20 June 2023.

In total, 40 million shares were placed at a price of SEK 140 per share, corresponding to a total value of SEK 5.6 billion.
Vinge’s team consisted of Sofie Bjärtun and Linnéa Sellström.

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

 Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

 Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025